Back

Clinical efficacy of heart failure guideline directed medical therapy in patients with titin-truncating variants-associated dilated cardiomyopathy

17 May 2025 (12:00 - 13:00)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - heart failure with HFrEF (2) Heart Failure with Reduced Ejection Fraction (HFrEF) HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Andraz Cerar

University Medical Centre Ljubljana, Ljubljana (Slovenia)

7 More presentations in this session

Presentation thumbnail
Association between ultra-short-term heart rate variability and atrial fibrillation in heart failure population
Doctor X. Tang (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
The prognostic value of the CONUT score in predicting long-term mortality in acute decompensated heart failure patients
Associate Professor S. Murat (Eskisehir, TR)
Abstract Slides Video
Presentation thumbnail
Is beta- blocker therapy beneficial among patients with heart failure and reduced ejection fraction with concomitant atrial fibrillation rhythm?
Doctor F. Bahouth (Nazareth, IL)
Abstract Slides Video
Presentation thumbnail
Qiliqiangxin improves cardiovascular outcomes in patients with heart failure and reduced ejection fraction irrespective of left ventricular ejection fraction
Doctor L. Shen (Glasgow, CN)
Abstract Slides Video
Presentation thumbnail
Role of telemedicine in improving care for heart failure patients
Doctor A. Bakhsh (Makkah, SA)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in chronic heart failure - heart failure with HFrEF (2)

The Event

Event poster

Heart Failure 2025

17 May 2025 12:00 CET
You may be interested in
thumbnail
Congress Presentation
Contemporary heart failure therapy and left ventricular remodeling in patients with familial dilated cardiomyopathy
thumbnail
Congress Presentation
Current treatment strategies and outcomes in familial dilated cardiomyopathy
thumbnail
Congress Presentation
Relationship between left ventricular reverse remodeling and guideline-directed medical therapy intensity in de novo heart failure with reduced ejection fraction patients: insight from TRANS-HF trial

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources